High-Potency Marijuana Impairs Executive Function and Inhibitory Motor Control
Top Cited Papers
- 29 March 2006
- journal article
- clinical trial
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 31 (10), 2296-2303
- https://doi.org/10.1038/sj.npp.1301068
Abstract
Human performance studies have usually relied on low-potency marijuana (4% THC) for determining THC-induced impairment. The present study was designed to assess the effects of high-potency marijuana (13% THC) on human performance. In all, 20 recreational users of marijuana participated in a double-blind, placebo controlled, three way cross-over study. The treatments consisted of single doses of 0, 250, and 500 g/kg THC. Performance tests were conducted at regular intervals between 15 min and 6 h postsmoking and included measures of motor control (Critical tracking task), executive function (Tower of London) motor impulsivity (Stop signal task), and risk taking (Iowa gambling task). THC significantly impaired performance in the Critical tracking task and decreased the number of correct decisions in the Tower of London task. In addition, THC significantly increased stop reaction time and the proportions of commission and omission errors in the Stop signal task. THC-induced impairments lasted up to 6 h postsmoking as indicated by the absence of a THC Time after smoking interaction. Effect sizes for performance impairments produced by THC 250 g/kg were relatively low but generally increased by a factor of two in case of THC 500 g/kg. These data suggest that high potency marijuana consistently impairs executive function and motor control. Use of higher doses of THC in controlled studies may offer a reliable indication of THC induced impairment as compared to lower doses of THC that have traditionally been used in performance studies.Keywords
This publication has 36 references indexed in Scilit:
- Neural substrates of faulty decision-making in abstinent marijuana usersNeuroImage, 2005
- The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for PsychosisNeuropsychopharmacology, 2004
- Cognitive and subjective dose-response effects of acute oral Δ 9 -tetrahydrocannabinol (THC) in infrequent cannabis usersPsychopharmacology, 2002
- Acute effects of oral cocaine on inhibitory control of behavior in humansDrug and Alcohol Dependence, 2002
- Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusersNeuropsychologia, 2001
- Emotion, Decision Making and the Orbitofrontal CortexCerebral Cortex, 2000
- The effects of cannabinoids on the brainProgress in Neurobiology, 1999
- Acute and Residual Effects of Marijuana in HumansPharmacology Biochemistry and Behavior, 1998
- Preference for high- versus low-potency marijuanaPharmacology Biochemistry and Behavior, 1994
- Delta-9-tetrahydrocannabinol content and human marijuana self-administrationPsychopharmacology, 1989